PE ratio relative to earnings growth — is the valuation justified?
| Symbol | Company | PEG | P/E | Growth | vs PHG |
|---|---|---|---|---|---|
| BSX | Boston Scientific Corporation | 0.33 | 20.9 | 63.3% | — |
| ZBH | Zimmer Biomet Holdings, Inc. | 0.65 | 23.9 | 36.8% | — |
| NVS | Novartis AG | 1.49 | 22.9 | 15.4% | — |
| STE | STERIS plc | 2.50 | 28.1 | 11.2% | — |